Elligo Health Research
Elligo accelerates clinical research with direct access to 150M patients and efficient management solutions.
Founded
2016Elligo accelerates clinical research with direct access to 150M patients and efficient management solutions.
Elligo Health Research was founded with the mission to accelerate clinical research by providing direct access to 150 million patients through their physicians. The company offers a range of services including patient recruitment and engagement, remote clinical research services, and comprehensive site management solutions. Their technology platform, IntElligo® Research Stack, supports efficient clinical trials, making research more accessible and streamlined. Elligo focuses on bridging the gap between patients and clinical research, aiming to improve healthcare outcomes through innovation.
Notable affiliated individuals include industry experts and seasoned professionals in clinical research and healthcare technology. Elligo has garnered significant investment from leading venture capital firms, which has enabled rapid growth and expansion. Key achievements include the successful integration of their technology in numerous clinical trials and partnerships with major healthcare providers. Elligo's impact is evident in their ability to bring more patients into the clinical research fold, thus accelerating the development of new treatments and therapies.
Companies similar to Elligo Health Research include Elite Clinical Network, Paradigm, SiteBridge Research and ObjectiveHealth.
Elligo Health Research was founded in 2016.
Elligo Health Research's headquarters is located in Austin, TX, US.
Elligo Health Research's most recent funding round was for $25M (USD) in October 2023.
As of Oct 2, 2023, Elligo Health Research has raised a total of $196M (USD).
Elligo Health Research has 443 employees as of Feb 5, 2024.
SiteBridge Research
